141 related articles for article (PubMed ID: 35562184)
1. Intracranial paragangliomas versus schwannomas: Role of dynamic susceptibility contrast perfusion and diffusion MRI.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
J Neuroimaging; 2022 Sep; 32(5):875-883. PubMed ID: 35562184
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 2 versus sporadic vestibular schwannoma: The utility of MR diffusion and dynamic contrast-enhanced imaging.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
J Neuroimaging; 2022 May; 32(3):554-560. PubMed ID: 35037337
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced magnetic resonance imaging for differentiating head and neck paraganglioma and schwannoma.
Malla SR; Bhalla AS; Manchanda S; Kandasamy D; Kumar R; Agarwal S; Shamim SA; Kakkar A
Head Neck; 2021 Sep; 43(9):2611-2622. PubMed ID: 33938085
[TBL] [Abstract][Full Text] [Related]
4. Dynamic susceptibility contrast and diffusion-weighted MRI in posterior fossa pilocytic astrocytoma and medulloblastoma.
Kurokawa R; Umemura Y; Capizzano A; Kurokawa M; Baba A; Holmes A; Kim J; Ota Y; Srinivasan A; Moritani T
J Neuroimaging; 2022 May; 32(3):511-520. PubMed ID: 34997668
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI.
Kurokawa R; Kurokawa M; Baba A; Kim J; Capizzano A; Bapuraj J; Srinivasan A; Moritani T
Medicine (Baltimore); 2022 Nov; 101(44):e31708. PubMed ID: 36343086
[TBL] [Abstract][Full Text] [Related]
6. MR diffusion and dynamic-contrast enhanced imaging to distinguish meningioma, paraganglioma, and schwannoma in the cerebellopontine angle and jugular foramen.
Ota Y; Liao E; Capizzano AA; Yokota H; Baba A; Kurokawa R; Kurokawa M; Moritani T; Yoshii K; Srinivasan A
J Neuroimaging; 2022 May; 32(3):502-510. PubMed ID: 34936708
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Role of Diffusion-Weighted and Dynamic Contrast-Enhanced Perfusion MR Imaging in Paragangliomas and Schwannomas in the Head and Neck.
Ota Y; Liao E; Capizzano AA; Kurokawa R; Bapuraj JR; Syed F; Baba A; Moritani T; Srinivasan A
AJNR Am J Neuroradiol; 2021 Oct; 42(10):1839-1846. PubMed ID: 34446460
[TBL] [Abstract][Full Text] [Related]
8. Advanced MRI to differentiate schwannomas and metastases in the cerebellopontine angle/internal auditory canal.
Ota Y; Liao E; Zhao R; Lobo R; Capizzano AA; Bapuraj JR; Shah G; Baba A; Srinivasan A
J Neuroimaging; 2022 Nov; 32(6):1177-1184. PubMed ID: 35879866
[TBL] [Abstract][Full Text] [Related]
9. Utility of dynamic susceptibility contrast MRI for differentiation between paragangliomas and meningiomas in the cerebellopontine angle and jugular foramen region.
Ota Y; Liao E; Zhao R; Capizzano AA; Baba A; Lobo R; Shah G; Srinivasan A
Clin Imaging; 2023 Apr; 96():49-55. PubMed ID: 36801537
[TBL] [Abstract][Full Text] [Related]
10. Precise differentiation between jugular foramen paragangliomas and metastases: utility of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging.
Ota Y; Curaudeau G; Liao E; Bapuraj J; Baba A; Shah G; Srinivasan A
Neuroradiology; 2023 Apr; 65(4):805-813. PubMed ID: 36635515
[TBL] [Abstract][Full Text] [Related]
11. Golden-Angle Radial Sparse Parallel (GRASP) MRI differentiates head & neck paragangliomas from schwannomas.
Demerath T; Blackham K; Anastasopoulos C; Block KT; Stieltjes B; Schubert T
Magn Reson Imaging; 2020 Jul; 70():73-80. PubMed ID: 32335122
[TBL] [Abstract][Full Text] [Related]
12. Dynamic susceptibility contrast perfusion-weighted and diffusion-weighted magnetic resonance imaging findings in pilocytic astrocytoma and H3.3 and H3.1 variant diffuse midline glioma, H3K27-altered.
Kurokawa R; Kurokawa M; Baba A; Kim J; Srinivasan A; Moritani T
PLoS One; 2023; 18(7):e0288412. PubMed ID: 37450487
[TBL] [Abstract][Full Text] [Related]
13. MR imaging features of benign retroperitoneal paragangliomas and schwannomas.
Shen Y; Zhong Y; Wang H; Ma L; Wang Y; Zhang K; Sun Z; Ye H
BMC Neurol; 2018 Jan; 18(1):1. PubMed ID: 29301496
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of Jugular Foramen Paragangliomas versus Schwannomas Using Golden-Angle Radial Sparse Parallel Dynamic Contrast-Enhanced MRI.
Pires A; Nayak G; Zan E; Hagiwara M; Gonen O; Fatterpekar G
AJNR Am J Neuroradiol; 2021 Oct; 42(10):1847-1852. PubMed ID: 34503944
[TBL] [Abstract][Full Text] [Related]
15. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
[TBL] [Abstract][Full Text] [Related]
16. The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study.
Lewis D; Donofrio CA; O'Leary C; Li KL; Zhu X; Williams R; Djoukhadar I; Agushi E; Hannan CJ; Stapleton E; Lloyd SK; Freeman SR; Wadeson A; Rutherford SA; Hammerbeck-Ward C; Evans DG; Jackson A; Pathmanaban ON; Roncaroli F; King AT; Coope DJ
J Neurosurg; 2020 May; 134(5):1419-1429. PubMed ID: 32470937
[TBL] [Abstract][Full Text] [Related]
17. Perfusion and diffusion-weighted imaging parameters: Comparison between pre- and postbiopsy MRI for high-grade glioma.
Kurokawa R; Baba A; Kurokawa M; Capizzano A; Ota Y; Kim J; Srinivasan A; Moritani T
Medicine (Baltimore); 2022 Sep; 101(35):e30183. PubMed ID: 36107564
[TBL] [Abstract][Full Text] [Related]
18. Low-dose T1W DCE-MRI for early time points perfusion measurement in patients with intracranial tumors: A pilot study applying the microsphere model to measure absolute cerebral blood flow.
Li KL; Lewis D; Jackson A; Zhao S; Zhu X
J Magn Reson Imaging; 2018 Aug; 48(2):543-557. PubMed ID: 29473980
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of normal-appearing white matter with perfusion and diffusion MRI in patients with treated glioblastoma.
Şahin S; Ertekin E; Şahin T; Özsunar Y
MAGMA; 2022 Feb; 35(1):153-162. PubMed ID: 34951690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
